Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Other Opioid Crisis

April 1, 2016 8:38 am | by Luke Messac, University of Pennsylvania, The Conversation | News | Comments

There are two opioid crises in the world today. Read more...


Tick Saliva Could Help Make New Blood Disorder Treatment

April 1, 2016 8:31 am | by Monash University | News | Comments

Scientists found a connection between tick saliva proteins and eculizumab. Read more...


Cancer Drug Could Treat Blood Vessel Deformities

April 1, 2016 8:31 am | by University College London | News | Comments

VMs are characterized by deformed, swollen blood vessels.


FDA Grants Approval for Roche to Test Blood Samples for Zika

April 1, 2016 8:30 am | News | Comments

Initially, the cobas Zika test will be deployed to screen blood donations collected locally in Puerto Rico. Read more...


New Method Measures Type 2 Diabetes Risk in Blood

April 1, 2016 8:30 am | by Lund University | News | Comments

The predictive potential of the current method is modest, but new methods are needed. Read more...


Pharmacy on Demand

April 1, 2016 8:29 am | by Anne Trafton, MIT News Office | News | Comments

New, portable system can be configured to produce different drugs. Read more...


GSK to Reduce Drug Patents in Poor Countries

March 31, 2016 1:16 pm | by Stephanie Guzowski, Editor | News | Comments

In an attempt to broaden global access to expensive medications, GlaxoSmithKline (GSK) announced Thursday it will adopt a graduated approach to patenting its drugs, depending on the wealth of countries. Read more..


Genfit Plans to Test Its Drug in Second Liver Disease

March 31, 2016 12:13 pm | by Bill Berkrot, Reuters | News | Comments

French drugmaker Genfit SA on Thursday said it would begin a midstage trial this year of its experimental drug elafibranor to treat primary biliary cholangitis, a chronic disease in which bile ducts in the liver are gradually destroyed. Read more...


Brilinta Preferred Over Clopidogrel in Updated Acute Coronary Syndrome Guidelines

March 31, 2016 10:52 am | News | Comments

First major US guideline to include expanded indication for Brilinta in patients with a heart attack beyond one year. Read more...


Janssen's Phase 3 Trial of Daratumumab in Multiple Myeloma Meets Primary Endpoint

March 31, 2016 10:45 am | News | Comments

Janssen announced today positive results of a pre-planned interim analysis of the Phase 3 MMY3004 (CASTOR) trial evaluating the efficacy and safety of daratumumab, a CD38-directed monoclonal antibody (mAb), in combination with bortezomib and dexamethasone, compared to bortezomib and dexamethasone alone, in patients with relapsed or refractory multiple myeloma. Read more...


Phase-3 Drug Trial for Refractory RA Succeeds, Stanford Scientist Says

March 31, 2016 10:34 am | by Stanford Unversity | News | Comments

In a pivotal phase-3 trial led by a Stanford University School of Medicine investigator, a novel drug for rheumatoid arthritis substantially reduced symptoms and improved daily physical functioning in patients for whom other therapies had failed. Read more..


JAMA Cardiology: Phase 2 Results of AC6 Gene Transfer in Patients with HF

March 31, 2016 10:27 am | News | Comments

Renova Therapeutics, a biopharmaceutical company developing gene therapy treatments for cardiovascular and metabolic diseases, announced the publication of Phase 2 clinical trial results of AC6 gene transfer for the treatment of patients with heart failure and reduced ejection fraction in JAMA Cardiology. Read more..


Valeant Tries to Delay Release of Financial Statements

March 31, 2016 8:53 am | by The Associated Press | News | Comments

The company needs an extension because if the annual report is not filed by April 29. Read more...


Embattled Stem Cell Scientist Says Charges Against Him Are False

March 31, 2016 8:50 am | by Maria Cheng, AP Medical Writer | News | Comments

Macchiarini's research was once thought to be revolutionary in the field of regenerative medicine. Read more...


Study Confirms Link Between Diabetes Drug, Higher Bladder Cancer Risk

March 31, 2016 8:47 am | by British Medical Journal | News | Comments

The diabetes drug pioglitazone is associated with an increased risk of bladder cancer. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.